Palantir Technologies Inc.NASDAQ:PLTR
Published 2026-11-03, with market data as of the 2026-11-02 close. Financials are sourced from Palantir's Q3 2026 report (issued after market close on 2026-11-02, SEC 8-K EX-99.1) and public filings.
Palantir delivered a textbook beat-and-raise: Q3'26 revenue of $2,313M (+96%, first $2B+ quarter), adjusted operating income of $1,427M (62% margin), GAAP net income of $1,128M (+137%), EPS of $0.44 (vs $0.41 consensus); U.S. commercial of $984M (+148%) surpassed U.S. government of $953M (+96%) for the first time in company history. Management raised FY26 revenue guidance to $8.53B (+91%, above the $8.2B consensus), U.S. commercial to >$3.56B (+143%), and FCF to $4.8-5.0B. Yet the stock fell ~3% after hours on this near-flawless report — at 34.5x forward sales and 125x trailing earnings, the market demands 'stunning' rather than merely 'great'.
We rate PLTR Buy with Medium conviction and a 12-month target of $202 (+13.3% vs spot). Core view: sovereign-AI-driven U.S. commercial acceleration (+148%) is a real, durable structural story, and the FY26 guidance raise pushes our FY27E revenue to $13.5B (between Goldman's $13.2B and Rosenblatt's $14.6B), which at 36x forward sales supports $202 — growth alone drives upside while the multiple roughly holds. But we are more conservative than the $218.95 Street consensus: the after-hours drop exposes a valuation ceiling, and any quarter below ~50% growth could trigger multiple compression, which is why we set our target 8% below the Street.
§01Investment Summary
Palantir's Q3'26 report marks a historic inflection in sovereign-AI commercialization: U.S. commercial revenue of $984M (+148%) surpassed U.S. government of $953M (+96%) for the first time — the growth engine long anchored in defense and government contracts has, at least in the U.S. market, officially shifted to commercial.
A tenth straight beat-and-raise: revenue +96% (first $2B+ quarter), adjusted operating margin of 62%, Rule of 40 of 158%, plus an FY26 guidance raise of $0.38B (+91%, above consensus). We cross-check three FY27E-revenue P/S scenarios (24/36/42x) to a probability-weighted $196.2, and adopt the $202 main path.
Reasons to Buy
- U.S. commercial +148% first surpassed government, upgrading sovereign AI from a 'defense narrative' to 'enterprise reality', with RDV of $6.52B (+79%) locking forward revenue visibility;
- a tenth straight beat-and-raise, with FY26 guidance raised $0.38B above consensus and Q4 guided to $2.65B vs $2.46B consensus (+8%), resetting estimates higher;
- hard cash-flow quality — adjusted FCF of $1,216M (53% margin) and $10.4B cash plus treasuries make this no mere 'AI narrative' stock.
- extreme valuation — 34.5x forward sales and 125x trailing earnings embed 80-90% growth, so any quarter below ~50% triggers multiple compression;
- international at only ~16% of revenue ($376M, derived) and growing far slower than the U.S. (+119%);
- the 'sell-the-news' inertia revealed by the after-hours drop — three straight beats with two next-day declines.
Unlock this and all institutional-grade research and analysis.
Institutional-grade analysis
Rigorous, evidence-based research that cuts through the noise.
Real-time quant tools
An AI agent wired into live charts and Radar.
AI quant ratings
Trade long and short with greater conviction.